Skip to content

Cataract & Refractive Surgery

One of the most important risk factors for Dry Eye are some ocular surgeries, such as Cataract and Refractive Surgeries, like nearsightedness (myopia), farsightedness (hyperopia), presbyopia or astigmatism—being LASIK (i.e., laser-assisted in situ keratomileusis) the most popular method applied.

After performing this type of surgery, most patients experience some eye disorders associated to the surgery, especially Dry Eye Disease (DED).

Suggested Protocol

Legend

Single usage
Joint usage
Application No. Sittings/Sessions Frequency
DAYS APART, UNLESS SPECIFIED
ApplicationCataract Surgery Technology LM® LLLT
Red
Blue
Yellow
Recommended Protocol > No. Sittings/Sessions 1x of 15min > Frequency 7±2 Days Before Surgery
Applicationi.e., Senile & Premium IOLs Technology
Red
Blue
Yellow
Recommended Protocol > No. Sittings/Sessions 1x of 15min > Frequency 7±2 Days After Surgery
ApplicationRefractive Surgery Technology LM® LLLT
Red
Blue
Yellow
Recommended Protocol > No. Sittings/Sessions 1x of 15min > Frequency 7±2 Days Before Surgery
Applicationi.e., LASIK, SMILE Technology
Red
Blue
Yellow
Recommended Protocol > No. Sittings/Sessions 1x of 15min > Frequency 14±2 Days After Surgery
Application
> Cataract Surgery
i.e., Senile & Premium IOLs
Cataract Surgery
Application
> Refractive Surgery
i.e., LASIK, SMILE
Refractive Surgery
Not all solutions and use cases are available in all countries. Clinical information displayed is derived from publicly available literature for scientific exchange. Please contact us to learn more about what solutions and use cases are available in your country.

Scientific Coverage

“Signs and symptoms of dry eye disease (DED) are highly prevalent in the postoperative course of patients undergoing cataract surgery, significantly impairing patients’ satisfaction with surgery and quality of life and vision.
Prophylactic treatment using low-level light therapy could be easily incorporated in the workflow of otherwise healthy patients undergoing senile cataract surgery in order to avoid iatrogenic DED.

GIANNACCARE, Giuseppe. Outcomes of low-level light therapy before and after cataract surgery for the prophylaxis of postoperative dry eye. The British Journal of Ophthalmology, 2023.

“Unresolved ocular surface disease (DED) represents a major risk factor for suboptimal outcomes in refractive surgery. Untreated preoperative dry eye disease (DED) and meibomian glands dysfunction (MGD) can impact the accuracy of refractive calculation and contribute to poor vision outcome. Existing DED, both asymptomatic and symptomatic, can be exacerbated during surgery and lead to postoperative patient dissatisfaction with their cataract procedure.

LABETOULLE, Marc. Making Treatment Decisions For Dry Eye Disease, ESCRS / EuCornea, 2020.

“In people with unstable tear film, there may be variation of more than 1.0D, which can correspond to an error of the same magnitude in lens power calculation and thus significantly impact vision.

ARZEL, Florian. Treatment of meibomian dysfunction by pulsed light and photo-biomodulation, Les Chaiers, 2021.

Get Started Now
Get in touch to find out how you can benefit from the Espansione Ecosystem of Technologies and Solutions.

In compliance with current regulations, let us know which audience you belong to:

You must fill in the form to download the file.

I want to be updated about Espansione products and services

This field is required.
This field is required.
This field is required.
A valid email address is required.
This field is required.
This field is required.
Select your role (Ophthalmology/Optometry)*
Select your role (Dermatology/Aesthetics)*
Sub-Specialty*
Sub-Specialty*
Other Specialty*
This field is required.
I have read the privacy policy and the terms and conditions of the site
This field is required.
I want to be updated about Espansione products and services. You can unsubscribe at any time, by using the “unsubscribe” feature at the bottom of any communication you receive.

Thank you for contacting us.